Connected With Latham
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.
info_outline
Episode 124 – The Growth Rocketship: Brave Capital, Defense Tech, Decisive Technologies!
09/17/2026
Episode 124 – The Growth Rocketship: Brave Capital, Defense Tech, Decisive Technologies!
San Francisco-based venture capital firm Brave Capital partners with companies from pre-seed through growth equity stages, backing transformative technology startups in sectors ranging from AI to aerospace and energy. The firm backs modern defense disruptors — known as “neoprimes” — that bridge the traditional military-industrial gap, with investments in companies such as . In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Ernestine Fu Mak, Founder and Managing Partner of , to discuss the firm’s approach to investing in decisive technologies, macro trends shaping AI and infrastructure, capital allocation strategies across early- and late-stage investments, and what drives one of the most dynamic investors in Silicon Valley history. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/42941797
info_outline
Episode 123 – The Growth Rocketship: Hercules Backs Tech, Life Sciences
09/03/2026
Episode 123 – The Growth Rocketship: Hercules Backs Tech, Life Sciences
Hercules Capital provides senior secured loans to high-growth, venture capital-backed companies across technology and life sciences. Since its inception in 2003, Hercules has committed more than US$28 billion to more than 700 companies and works with more than 1,000 leading venture capital and private equity firms. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with , Chief Executive Officer and Chief Investment Officer of Hercules Capital, to discuss Hercules’ investment approach, the role of venture debt in the current market, and how AI could shape the future of technology and life sciences markets. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/42731875
info_outline
Episode 122 – Europe Litigation: Mass Actions at a Global Scale
08/14/2026
Episode 122 – Europe Litigation: Mass Actions at a Global Scale
Europe has entered the collective redress era. The full implementation of the EU Representative Actions Directive, coupled with a surge in litigation funding, has transformed the ability of claimant groups to coordinate across jurisdictions. Companies now face the prospect of parallel consumer, data privacy, and competition actions that are global in scope — which means the challenge for defendants is not just winning individual cases, but managing consistency of arguments, data strategies, and settlement approaches across multiple fronts. In this episode of Connected With Latham, London partners and and Hamburg partner discuss how the EU Representative Actions Directive affects mass actions, the UK’s response to the Directive, and what clients can do to navigate potential challenges. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/42439215
info_outline
Episode 121 – The Growth Rocketship: Inside Boutique Venture With NewView Capital
06/30/2026
Episode 121 – The Growth Rocketship: Inside Boutique Venture With NewView Capital
California-based venture capital and growth firm with more than US$3 billion under management, NewView Capital invests in high-potential technology companies on a primary, secondary, or hybrid basis. Founded in 2018, NewView has emerged as an early leader in the secondary market, taking a boutique, high-conviction approach to backing category-defining companies. Latham has advised NewView on a range of primary, secondary, and hybrid investments across the US and around the world. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with NewView Capital Partner Ankit Sud to discuss the firm’s thematic investment philosophy, its leadership in the secondary market, and how NewView helps portfolio companies reinvent themselves in the AI era. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41907100
info_outline
Episode 120 – The Growth Rocketship: Modernizing Real Estate With Opendoor
06/18/2026
Episode 120 – The Growth Rocketship: Modernizing Real Estate With Opendoor
Residential real estate platform Opendoor puts homeowners in control by replacing the traditional, passive home-selling process with a streamlined e-commerce system. Founded in 2014, Opendoor has since expanded its reach across the lower 48 states, building out a partner network and tackling the complex ecosystem of utilities, title, escrow, and mortgage that surrounds every home sale. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Christy Schwartz, Opendoor’s Chief Financial Officer, and Rishi Kotiya, Head of Legal and Corporate Secretary, to discuss how OpenDoor is modernizing the home-selling experience at scale, navigating the operational and regulatory complexity behind residential real estate, and how AI is supporting the company’s next phase of growth. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41692785
info_outline
Episode 119 – The Growth Rocketship: How Rakuten Capital Masters Diplomatic Capitalism
06/04/2026
Episode 119 – The Growth Rocketship: How Rakuten Capital Masters Diplomatic Capitalism
The corporate venture capital arm of Rakuten Group, Rakuten Capital invests in innovative startups across fintech, AI, and other high-growth sectors. Since its founding in 2014, Rakuten Capital has invested in companies like Lyft, Pinterest, Careem, and Upstart, establishing itself as a distinctive force in corporate venture investing. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Saemin Ahn, Managing Partner of Rakuten Capital and Executive Officer of Rakuten Group, to discuss Rakuten Capital’s investment thesis, its approach to AI infrastructure and energy, and the art of diplomatic capitalism. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41537195
info_outline
Episode 118 – The Growth Rocketship: Axiado Takes Cybersecurity Inside the Rack
05/29/2026
Episode 118 – The Growth Rocketship: Axiado Takes Cybersecurity Inside the Rack
Founded in 2020, Axiado deploys hardware-anchored, AI-driven platform security by embedding silicon directly on the rack, protecting AI and cloud infrastructure against cyberattacks in real time. Latham represented Axiado in its oversubscribed US$100+ million Series C+ funding round. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Gopi Sirineni, Founder, President, and CEO of Axiado, to discuss the company’s proximity-based security approach, the evolving cybersecurity landscape for AI infrastructure, and India’s growing role in the global semiconductor ecosystem. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41465595
info_outline
Episode 117 – The Growth Rocketship: Using AI to Accelerate Analog Semiconductor Design With Celera
05/21/2026
Episode 117 – The Growth Rocketship: Using AI to Accelerate Analog Semiconductor Design With Celera
Celera Semiconductor aims to radically accelerate the development of analog semiconductor chips using AI. Founded in 2018, Celera has raised US$34 million in funding, including a recent Series A led by Maverick Silicon that Latham advised on. The company partners with the world’s largest independent analog fab to engage customers in high-growth industries like data centers, consumer electronics, and industrial components. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Celera’s Chief Executive Officer, Patrick Brockett and Chief Operating Officer, Alberto Viviani, to discuss the technology breakthrough behind Celera’s platform, its go-to-market strategy in the booming custom analog segment, and the talent, capital, and macro trends shaping the future of AI-driven semiconductor design. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41379185
info_outline
Episode 116 – Drug Pricing and Market Access: CMS Update With Rujul Desai
05/13/2026
Episode 116 – Drug Pricing and Market Access: CMS Update With Rujul Desai
The Trump administration has advanced many policy initiatives in the drug pricing and market access area, and CMS —the Centers for Medicare & Medicaid Services — is the agency at the heart of many of these efforts. Rujul Desai, Senior Counselor to CMS and former Deputy General Counsel at the Department of Health & Human Services, joins Washington, D.C. partner and associate for an update on key CMS priorities. Rujul also discusses the transition from big law to government and shares practice pointers for engaging with the agency. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41284860
info_outline
Episode 115 – Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
04/27/2026
Episode 115 – Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Washington, D.C. partner , and associates and , share observations and insights from the recent Centers for Medicare & Medicaid Services (CMS) Quality Conference and the American Health Law Association’s Institute on Medicare and Medicaid Payment Issues conference. They also discuss updates that government speakers shared at these events. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/41035740
info_outline
Episode 114 – The Growth Rocketship: Using AI and Human Expertise to Build Tomorrow’s Leading Brands With A-Frame
04/23/2026
Episode 114 – The Growth Rocketship: Using AI and Human Expertise to Build Tomorrow’s Leading Brands With A-Frame
identifies emerging signals in culture, consumer behavior, and category white space — then moves fast to bring the right products to shelf. They work two ways: co-creating private-label and exclusive product lines with the world’s leading retailers, building a portfolio of standalone brands with world-class talent partners across beauty, personal care, fragrance, home care, and pet care. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with A-Frame’s Founder and CEO, Ari Bloom, to discuss A-Frame’s business model, how the company has evolved, and what draws retailers and talent partners to A-Frame. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/40995235
info_outline
Episode 113 – Helping Holocaust Survivors
04/21/2026
Episode 113 – Helping Holocaust Survivors
Over two decades, more than 350 Latham lawyers have taken on Holocaust reparations matters, helping Holocaust survivors apply for pensions for work performed in Nazi-controlled ghettos during World War II. In this episode of Connected With Latham, , Public Service Counsel and Director of Global Pro Bono at Latham, sits down with Anna Bravo, Attorney Support Manager and longtime leader of the firm’s Holocaust reparations program, and Isabelle Sarfati, the daughter of a Holocaust survivor client. Together, they reflect on the completion of Latham’s final reparations case in 2025, the challenges survivors faced in documenting their experiences, and how Isabelle’s curiosity and research about her father’s experience in the Warsaw Ghetto ultimately led to a successful outcome for her family. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/40959635
info_outline
Episode 112 – The Growth Rocketship: Navigating the Institutional Evolution of the Blockchain World With ParaFi
04/14/2026
Episode 112 – The Growth Rocketship: Navigating the Institutional Evolution of the Blockchain World With ParaFi
ParaFi Capital is an alternative asset management and technology firm focused on blockchain and digital assets. Founded in 2018, the firm was among the earliest institutional investors in the blockchain industry and has evolved into a trusted partner to leading institutions around the world. Latham has advised ParaFi on a range of strategic investments across the digital asset ecosystem, including venture financings and DeFi transactions. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with ParaFi’s Founder and Managing Partner, Ben Forman, and Chief Operating Officer and Partner, Adrian Uberto, to discuss the company’s growth journey, the macro and AI trends shaping the future of blockchain and cryptocurrency, and how ParaFi is positioned to navigate them. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/40872935
info_outline
Episode 111 – The Growth Rocketship: The Future of Rewards-Based Advertising With Fetch
03/10/2026
Episode 111 – The Growth Rocketship: The Future of Rewards-Based Advertising With Fetch
Founded in 2013, is a daily rewards destination for consumers and brands, turning everyday actions like shopping, dining out, and playing games into tangible value for consumers while delivering measurable advertising for consumer, retail, and restaurant brands. Latham represented Fetch on a series of strategic growth financing transactions in 2025. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Fetch’s Chief Financial Officer Gideon Oppenheimer and General Counsel Dave Toomey to explore macro shifts in advertising, capital allocation tradeoffs, expansion into new verticals like fitness and health, and creating a transparent, privacy-forward ecosystem powered by AI to build long-term trust with users. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/40384385
info_outline
Episode 110 – Spotlight on US State Healthcare Transaction Review Laws
02/18/2026
Episode 110 – Spotlight on US State Healthcare Transaction Review Laws
States continue to expand their review of healthcare transactions involving private equity, real estate investment trusts, management services organizations, and other investors. Join Washington, D.C. counsel , Los Angeles counsel , and Washington, D.C. associate as they discuss how the increased level of state regulatory oversight affect health services transactions and key takeaways for investors looking to purchase healthcare companies this year. Also check out our report: This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/40152635
info_outline
Episode 109 – Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026
02/03/2026
Episode 109 – Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026
The drug pricing and market access policy space saw a lot of change in 2025, and the pace is not slowing down. In this episode of Connected With Latham, pharmaceutical industry veteran , founder of Aery Policy and Access Partners, joins Washington, D.C. partner and associate for a wide-ranging discussion of key 2025 takeaways and what to expect in 2026. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/39981765
info_outline
Episode 108 – UK FinReg Focus Areas in 2026
01/12/2026
Episode 108 – UK FinReg Focus Areas in 2026
In this episode of Connected with Latham, complementing Latham’s “ in 2026” report, London partners and and counsel discuss the key trends for financial services firms in 2026. Amongst other topics, they discuss the Leeds Reforms, the ESG landscape, and enforcement trends. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/39699480
info_outline
Episode 107 – Drug Pricing and Market Access: “Think of It as a Loop” — Succeeding in an Evolving Policy Landscape
12/16/2025
Episode 107 – Drug Pricing and Market Access: “Think of It as a Loop” — Succeeding in an Evolving Policy Landscape
The pharmaceutical industry has seen major legal and policy changes in recent years, from the Inflation Reduction Act to the Trump administration’s aggressive pricing policies. In this episode of Connected With Latham, Mike Domanico, a pharmaceutical industry veteran with experience in Big 4, brand drugs, biosimilars, and generics, and most recently Vice President of Revenue Finance, joins Washington, D.C. partner and associate to discuss how organizations can best respond to the changing environment. As Mike explains, think of meeting the challenge as a loop that connects the business, compliance, and legal in a cross-functional collaboration. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/39417600
info_outline
Episode 106 – The FDA’s New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
12/15/2025
Episode 106 – The FDA’s New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway
Recent FDA actions are reshaping key aspects of drug and biologic development, including the Commissioner’s National Priority Voucher program, the “plausible mechanism” pathway for personalized therapies, and new draft guidance aimed at streamlining biosimilars and interchangeables. Join Washington, D.C. partner and counsel and as they discuss how these moves differ from traditional policy-making, as well as the practical implications for pricing, manufacturing, M&A, and litigation risk in the healthcare and life sciences industry. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/39413965
info_outline
Episode 105 – Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits
11/24/2025
Episode 105 – Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits
Government pricing assessments are an important tool to help pharmaceutical manufacturers review their government price reporting function. They can also help uncovering strategic benefits and opportunities. In this episode of Connected With Latham, , Managing Director at Ernst & Young LLP, joins Washington, D.C. partner and associate to explore how these assessments are conducted, the compliance benefits they offer, and the strategic insights they can provide. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/39153660
info_outline
Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner’s National Priority Voucher Program Awards
11/03/2025
Episode 104 – Drug Pricing and Market Access: Deep Dive on the FDA Commissioner’s National Priority Voucher Program Awards
The new FDA Commissioner’s National Priority Voucher (CNPV) pilot program promises to reduce recipients’ application review times from 10-12 months to just 1-2 months. As part of the Trump administration’s push for most favored nation (MFN) pricing, drug affordability is one criterion for vouchers, marking FDA’s entry into the drug pricing fray. In this episode of Connected With Latham, Washington, D.C. partner and counsel explore the in detail and discuss how the accelerated review period might affect launch strategies, whether companies with no voucher will be disadvantaged, and potential risks and concerns. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/38899740
info_outline
Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
10/02/2025
Episode 103 – Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit
Stakeholders from across the healthcare industry — from manufacturers and consultants to outside counsel and government officials — recently convened in Chicago for the Medicaid Drug Rebate Program Summit 2025. In this episode of Connected With Latham, Washington, D.C. partner , counsel , and associate share impressions and key takeaways from the conference, including action items like readying litigation support to address likely future challenges. Also check out our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/38441600
info_outline
Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services
09/11/2025
Episode 102 – EU Data Act: Spotlight on Switching Requirements for Data Processing Services
In this episode of Connected With Latham, London partner , Paris partner , and London counsel discuss significant new switching requirements due to take effect for data processing services under the EU Data Act. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/38187925
info_outline
Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity
09/10/2025
Episode 101 – EU Data Act: Implications for Data Privacy and Cybersecurity
In this episode of Connected With Latham, London partner and Frankfurt partner discuss the EU Data Act, and what this means for data privacy and cybersecurity practices. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/38172940
info_outline
Episode 100 – The Leeds Reforms: Implications for UK Financial Services
07/17/2025
Episode 100 – The Leeds Reforms: Implications for UK Financial Services
In this episode of Connected with Latham, London partners and discuss the UK government’s plans for the financial services sector, and key takeaways for financial services firms. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/37449045
info_outline
Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference
06/24/2025
Episode 99 – Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference
Current developments, such as most favored nation (MFN) pricing, grabbed much of the spotlight when key industry stakeholders met in Philadelphia for the Pricing and Contracting USA Conference. In this episode of Connected With Latham, Allan Thoen, Director & Associate General Counsel with Sandoz, joins Washington, D.C. partner and associate to discuss impressions and takeaways from the conference. And read our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/37136665
info_outline
Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting
06/06/2025
Episode 98 – Drug Pricing: Takeaways from the MDMA Annual Meeting
Stakeholders from across the healthcare industry, including members of Congress, the US Food and Drug Administration, and the Center for Medicare and Medicaid Services, recently convened in Washington D.C. for the Medical Device Manufacturers Association (MDMA) Annual Meeting. In this episode of Connected With Latham, Washington, D.C. partners , , and , and associate share their key takeaways from the meeting, including compliance hot topics and what the industry can expect in terms of regulatory enforcement in 2025. Read our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/36891580
info_outline
Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation
05/02/2025
Episode 97 – Drug Pricing: How the Drug Pricing EO Impacts FDA and Overlaps with Grassley-Led Legislation
The “Lowering Drug Prices by Once Again Putting Americans First” addresses various FDA matters, such as importation from Canada and accelerated approval of generics and biosimilars. In this episode of Connected With Latham, Washington, D.C. partners , , and analyze these FDA implications, and explore how the EO overlaps with championed by Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa). Also check out Chris’s interview with Life Sciences IP Review about industry impacts of the Grassley bills. And yes, it’s back: Read our bi-weekly on the website or to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/36415070
info_outline
Episode 96 – The Growth Rocketship: Shield AI’s Takeoff Shows What’s Possible in Defensetech
04/30/2025
Episode 96 – The Growth Rocketship: Shield AI’s Takeoff Shows What’s Possible in Defensetech
Founded in 2015, uses technology and intelligence systems to protect service members and civilians. The venture-backed unicorn’s flagship autonomy software, Hivemind, powers aircraft, drones, and other platforms to reliably support complex missions in contested environments. Latham represented Shield AI on its US$240 million strategic funding round, raising the company’s valuation to US$5.3 billion, in March 2025. In this episode of Connected with Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, engages in a dynamic conversation with Shield AI’s Chief Financial Officer Kingsley Afemikhe and Chief Legal and Information Officer Jim Carlson. They discuss Shield AI’s historic Series F1 fundraising, the macro trends in defense and AI shaping the future, and the company’s strategic positioning to navigate these developments. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/36375050
info_outline
Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE
03/12/2025
Episode 95 – Drug Pricing: FDA in the Age of Executive Orders and DOGE
The initial months of the Trump administration have been marked by a flurry of executive orders and significant activity by the Department of Government Efficiency (DOGE). The US Food and Drug Administration is a key target of these efforts. In this episode of Connected With Latham, Washington, D.C. partners and and associate explore how FDA may be affected, particularly as it relates to novel tobacco and nicotine products, which can be a bellwether for approval and enforcement trends more generally. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200
/episode/index/show/connectedwithlatham/id/35660800